Follow
Rene Gerolami
Rene Gerolami
Universite de la Mediterranee
Verified email at ap-hm.fr
Title
Cited by
Cited by
Year
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
J Bruix, S Qin, P Merle, A Granito, YH Huang, G Bodoky, M Pracht, ...
The Lancet 389 (10064), 56-66, 2017
34332017
Pig liver sausage as a source of hepatitis E virus transmission to humans
P Colson, P Borentain, B Queyriaux, M Kaba, V Moal, P Gallian, L Heyries, ...
The Journal of infectious diseases 202 (6), 825-834, 2010
7892010
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma …
V Vilgrain, H Pereira, E Assenat, B Guiu, AD Ilonca, GP Pageaux, A Sibert, ...
The Lancet Oncology 18 (12), 1624-1636, 2017
7622017
Chronic hepatitis E with cirrhosis in a kidney-transplant recipient
R Gérolami, V Moal, P Colson
New England Journal of Medicine 358 (8), 859-860, 2008
4352008
Outcomes of sequential treatment with sorafenib followed by regorafenib for HCC: additional analyses from the phase III RESORCE trial
RS Finn, P Merle, A Granito, YH Huang, G Bodoky, M Pracht, O Yokosuka, ...
Journal of hepatology 69 (2), 353-358, 2018
3392018
Treatment of severe acute hepatitis E by ribavirin
R Gerolami, P Borentain, F Raissouni, A Motte, C Solas, P Colson
Journal of clinical virology 52 (1), 60-62, 2011
2012011
Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies
M Bourliere, G Penaranda, C Renou, D Botta‐Fridlund, A Tran, I Portal, ...
Journal of viral hepatitis 13 (10), 659-670, 2006
1782006
RESORCE Investigators Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled …
J Bruix, S Qin, P Merle, A Granito, YH Huang, G Bodoky, M Pracht, ...
Lancet 389 (10064), 56-66, 2017
1662017
Autochthonous infections with hepatitis E virus genotype 4, France
P Colson, P Romanet, V Moal, P Borentain, R Purgus, A Benezech, ...
Emerging infectious diseases 18 (8), 1361, 2012
1372012
A national survey of acute hepatitis E in France
C Renou, X Moreau, A Pariente, JF CADRANEL, E Maringe, T Morin, ...
Alimentary pharmacology & therapeutics 27 (11), 1086-1093, 2008
1332008
Safety of TNF-blocking agents in rheumatic patients with serology suggesting past hepatitis B state: results from a cohort of 21 patients
C Charpin, S Guis, P Colson, P Borentain, JP Mattéi, P Alcaraz, ...
Arthritis research & therapy 11, 1-5, 2009
1252009
Hepatitis E virus as an emerging cause of chronic liver disease in organ transplant recipients
R Gérolami, V Moal, C Picard, P Colson
Journal of hepatology 50 (3), 622-624, 2009
1232009
Clinical and virological significance of the co-existence of HBsAg and anti-HBs antibodies in hepatitis B chronic carriers
P Colson, P Borentain, A Motte, M Henry, V Moal, D Botta-Fridlund, ...
Virology 367 (1), 30-40, 2007
1192007
Whipple’s disease: immunospecific and quantitative immunohistochemical study of intestinal biopsy specimens
H Lepidi, F Fenollar, R Gerolami, JL Mege, MF Bonzi, M Chappuis, ...
Human pathology 34 (6), 589-596, 2003
1162003
Clinical and virological factors associated with hepatitis B virus reactivation in HBsAg‐negative and anti‐HBc antibodies‐positive patients undergoing chemotherapy and/or …
P Borentain, P Colson, D Coso, E Bories, A Charbonnier, AM Stoppa, ...
Journal of viral hepatitis 17 (11), 807-815, 2010
1142010
Long-term radioiodine retention and regression of liver cancer after sodium iodide symporter gene transfer in wistar rats
J Faivre, J Clerc, R Gérolami, J Hervé, M Longuet, B Liu, J Roux, F Moal, ...
Cancer Research 64 (21), 8045-8051, 2004
1122004
Quantitative Detection of Tropheryma whipplei DNA by Real-Time PCR
F Fenollar, PE Fournier, D Raoult, R Gérolami, H Lepidi, C Poyart
Journal of clinical microbiology 40 (3), 1119-1120, 2002
1002002
Transduction efficacy, antitumoral effect, and toxicity of adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir therapy of hepatocellular carcinoma: the …
R Bilbao, R Gérolami, MP Bralet, C Qian, PL Tran, B Tennant, J Prieto, ...
Cancer Gene Therapy 7 (5), 657-662, 2000
932000
Clinical phenotype and outcome of hepatitis E virus–associated neuralgic amyotrophy
JJJ Van Eijk, HR Dalton, P Ripellino, RG Madden, C Jones, M Fritz, ...
Neurology 89 (9), 909-917, 2017
922017
Treatment of autochthonous acute hepatitis E with short‐term ribavirin: a multicenter retrospective study
JM Péron, F Abravanel, M Guillaume, R Gérolami, J Nana, R Anty, ...
Liver International 36 (3), 328-333, 2016
892016
The system can't perform the operation now. Try again later.
Articles 1–20